Prognosis

J&J Takes Over at Emergent Vaccine Plant With Aid From Biden

AstraZeneca agrees to move production out of Baltimore plant
J&J taking “full responsibility” at plant after major error

White House 'Assured' J&J Will Meet Vaccine Shipment Targets

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Josh Wingrove, Eduard Gismatullin, and Riley Griffin

April 4, 2021 at 1:02 AM UTC

Updated on

April 4, 2021 at 4:09 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Johnson & Johnson, with help from the Biden administration, is taking over a Baltimore vaccine production facility that was the site of a major manufacturing error last month -- and moving production of material for a second company’s shot to minimize risk of another mistake.